Publications by authors named "Elif Atag"

Claim this Profile
P
Prognostic importance of CD47 expression on survival of colorectal cancer.
Oktay Halit Aktepe, Olcay Kurtulan, Pinar Ezgi Dama, Eda Caliskan Yildirim, Aytac Terzi, Elif Atag

BMC Gastroenterol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of HER2 Status on Gastric Cancer Survival and the Clinical Implications of the HER2-Low Definition: A Retrospective Study.
Mehmet Uzun, Savas Gokcek, Melis Kilinc, Ferhat Ekinci, Tugay Avci, Elif Atag

Medicina (Kaunas)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total cholesterol/high-density lipoprotein cholesterol ratio is a candidate predictor of survival outcomes in patients with metastatic renal cell carcinoma.
Oktay Halit Aktepe, Ozge Yetginoglu, Mehmet Sinan Akarca, Canberk Sencan, Ahmet Unal, Elif Atag

Sci Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
THSD7A as a novel prognostic factor for colorectal carcinoma.
Oktay Halit Aktepe, Olcay Kurtulan, Pinar Ezgi Dama, Ahmet Melih Arslan, Elif Atag

BMC Gastroenterol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving treatment goals in older breast cancer patients receiving neoadjuvant chemotherapy.
Eda Caliskan Yildirim, Elif Atag, Huseyin Salih Semiz, Olcun Umit Unal, Mehmet Uzun

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study.
Nargiz Majidova, Hacı Arak, Faruk Recep Ozalp, Onur Bas, Gulhan Ozcelik Koker, Elif Atag

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study.
Serhat Sekmek, Irfan Karahan, Gokhan Ucar, Furkan Ceylan, Dogan Bayram, Elif Atag

Clin Transl Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does immunohistochemical marker conversion affect the prognosis in breast cancer patients receiving neoadjuvant chemotherapy?
Mehmet Uzun, Elif Atag, Eda Caliskan Yildirim, Murat Keser, Huseyin Salih Semiz

Sci Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study.
Eda Caliskan Yildirim, Elif Atag, Ezgi Coban, Olcun Umit Unal, Abdussamet Celebi

Breast· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does neoadjuvant chemotherapy provide any benefit for surgical de-escalation in luminal B, HER2(-) breast cancers?
Aysegul Aktas, Meryem Gunay-Gurleyik, Fugen Aker, Yasar Kaan-Akgok, Elif Atag

Cir Cir· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer.
Baran Akagündüz, Deniz Can Guven, Muhammet Ozer, Ilker Nihat Okten, Elif Atag

J Geriatr Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma.
Huseyin Salih Semiz, Emel Ebru Pala, Behzat Can, Elif Atag, Hatice Gungor

Turk Patoloji Derg· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Syrian Refugee and Turkish Women with Breast Cancer: A Comparison on Clinicopathological Features and Survival.
Elif Atag, Serkan Gokcay, Eda Tanrikulu Simsek, Fatih Aslan, Abdullah Evren Yetisir

Arch Iran Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD47 (don't eat me signal) expression levels and its relationship with clinicopathologic features in early-stage prostate carcinoma.
Hüseyin S Semiz, Ülkü Küçük, Erdem Kısa, Merve Keskinkılıç, Dilara Ecem Süyün

Prostate· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Is Your Choice for Androgen Deprivation Therapy in Metastatic Prostate Carcinoma: Surgical or Medical?
Huseyin Salih Semiz, Erdem Kisa, Eda Caliskan Yildirim, Elif Atag, Mehmet Emin Arayici

Turk J Urol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of FDG-PET/CT on Clinical Prognostic Staging of Breast Cancer Patients being Planned Neoadjuvant Treatment.
Eda Tanrikulu Simsek, Ezgi Coban, Elif Atag, Serkan Gungor, Fugen Aker

J Coll Physicians Surg Pak· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deficient Mismatch Repair and Lymphocytic Response to Tumor as Prognostic Markers in Stage II Colon Cancer Patients.
Murat Sari, Elif Atag, Tarik Demir, Eda Tanrikulu Simsek, Ezgi Coban

J Coll Physicians Surg Pak· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences.
Deniz Tural, Ömer Fatih Ölmez, Ahmet Taner Sümbül, Mehmet Artaç, Nail Özhan

Eur Urol Focus· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab.
Deniz Tural, Ömer Fatih Ölmez, Ahmet Taner Sümbül, Nail Özhan, Burcu Çakar

Int J Clin Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of FDG PET/CT to Evaluation of Axillary Lymph Nodes after Neoadjuvant Chemotherapy in Breast Cancer.
Eda Tanrikulu Simsek, Ezgi Coban, Elif Atag, Serkan Gungor, Murat Sari

J Coll Physicians Surg Pak· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of depressive symptoms in elderly cancer patients receiving chemotherapy and influencing factors.
Elif Atag, Feyza Mutlay, Pinar Soysal, Huseyin S Semiz, Seher N Kazaz

Psychogeriatrics· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study.
Tarik Salman, Seher Nazli Kazaz, Umut Varol, Utku Oflazoglu, Ilkay Tugba Unek, Elif Atag

Chemotherapy· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Cabazitaxel Beyond 20 Cycles in A Patient with Penile Metastasis of Prostate Cancer: A Case Report.
Elif Atag, Huseyin Salih Semiz, Seher Nazli Kazaz, Emine Burcin Tuna, Ozhan Ozdogan

Urol J· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Rate of Neoadjuvant Chemotherapy Use in Muscle Invasive Bladder Cancer and The Approach of Urologists in Turkey.
Oktay Üçer, Ali Can Albaz, Elif Atag, Aziz Karaoglu, Talha Muezzinoglu

Urol J· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis